These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1073 related items for PubMed ID: 16115227

  • 1. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C, Going J, Neilson L, Mackay C, Stuart RC.
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [Abstract] [Full Text] [Related]

  • 2. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
    Yagi K, Nakamura A, Sekine A.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
    [Abstract] [Full Text] [Related]

  • 3. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
    DeMeester SR, Wickramasinghe KS, Lord RV, Friedman A, Balaji NS, Chandrasoma PT, Hagen JA, Peters JH, DeMeester TR.
    Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
    [Abstract] [Full Text] [Related]

  • 4. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.
    Couvelard A, Cauvin JM, Goldfain D, Rotenberg A, Robaszkiewicz M, Fléjou JF, Groupe d'Etude l'Oesophage de Barrett.
    Gut; 2001 Dec; 49(6):761-6. PubMed ID: 11709508
    [Abstract] [Full Text] [Related]

  • 5. Etiology of intestinal metaplasia at the gastroesophageal junction.
    Balaji NS, DeMeester SR, Wickramasinghe KS, Hagen JA, Peters JH, DeMeester TR.
    Surg Endosc; 2003 Jan; 17(1):43-8. PubMed ID: 12364989
    [Abstract] [Full Text] [Related]

  • 6. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
    Mohammed IA, Streutker CJ, Riddell RH.
    Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
    [Abstract] [Full Text] [Related]

  • 7. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
    Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P.
    Histol Histopathol; 2002 Apr; 17(2):445-54. PubMed ID: 11962749
    [Abstract] [Full Text] [Related]

  • 8. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
    Tuncer I, Ugraş S, Uygan I, Türkdoğan K, Kösem M.
    Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
    [Abstract] [Full Text] [Related]

  • 9. [Cytokeratin immunoreactivity patterns in the diagnosis of Barrett's esophagus].
    Wang R, Xie J, Shen Y, Ren T.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1820-3. PubMed ID: 23268419
    [Abstract] [Full Text] [Related]

  • 10. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
    Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL.
    Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
    [Abstract] [Full Text] [Related]

  • 11. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Perez-Perez GI, Rice TW, Blaser MJ, Richter JE.
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [Abstract] [Full Text] [Related]

  • 12. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [Abstract] [Full Text] [Related]

  • 13. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB, Boparai V, Ullah N, Triadafilopoulos G.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):637-43. PubMed ID: 15352912
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
    Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM.
    Am J Gastroenterol; 2002 Feb 15; 97(2):302-11. PubMed ID: 11866266
    [Abstract] [Full Text] [Related]

  • 15. Modified classification for adenocarcinoma of the gastro-oesophageal junction.
    Shearer CJ, Going JJ, Neilson LJ, Stuart RC.
    ANZ J Surg; 2007 Jul 15; 77(7):544-9. PubMed ID: 17610690
    [Abstract] [Full Text] [Related]

  • 16. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P.
    Aliment Pharmacol Ther; 2004 Oct 15; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [Abstract] [Full Text] [Related]

  • 17. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
    Schilling D, Spiethoff A, Rosenbaum A, Hartmann D, Eickhoff A, Jakobs R, Weickert U, Rebe M, Bohrer MH, Riemann JF.
    Pathol Res Pract; 2005 Oct 15; 200(11-12):801-5. PubMed ID: 15792123
    [Abstract] [Full Text] [Related]

  • 18. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R.
    Aliment Pharmacol Ther; 2006 Jan 15; 23(2):321-9. PubMed ID: 16393313
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of cytokeratin immunoreactivity pattern for distinction of Barrett's esophagus from intestinal metaplasia of the stomach.
    Iwata T, Kurita N, Nishioka M, Hidenori M, Wakatsuki S, Sano T, Shimada M.
    Hepatogastroenterology; 2007 Sep 15; 54(78):1710-2. PubMed ID: 18019700
    [Abstract] [Full Text] [Related]

  • 20. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
    Liu GS, Gong J, Cheng P, Zhang J, Chang Y, Qiang L.
    World J Gastroenterol; 2005 Oct 28; 11(40):6360-5. PubMed ID: 16419166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.